(Q46468654)

English

Graft function, cardiovascular risk factors, and sex hormones in renal transplant recipients on an immunosuppressive regimen of everolimus, reduced dose of cyclosporine, and basiliximab.

scientific article published in April 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15866684%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Graft function, cardiovascular risk factors, and sex hormones in renal transplant recipients on an immunosuppressive regimen of everolimus, reduced dose of cyclosporine, and basiliximab (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15866684%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference

based on heuristic

inferred from title

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15866684%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

B K Krämer

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15866684%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

H-H Neumayer

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15866684%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

R Stahl

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15866684%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

M Pietrzyk

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15866684%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

B Krüger

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15866684%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

B Pfalzer

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15866684%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

B Bourbigot

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15866684%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

S Campbell

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15866684%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

J Whelchel

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15866684%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

J Eris

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15866684%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

S Vitko

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15866684%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

RADA2307 Study Group

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15866684%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

language of work or name

0 references

publication date

1 April 2005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15866684%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Transplantation Proceedings

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15866684%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

37

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15866684%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15866684%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1601-1604

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15866684%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Improved graft survival after renal transplantation in the United States, 1988 to 1996

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.09.026

7 January 2021

Early clinical experience with a novel rapamycin derivative

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.09.026

7 January 2021

Prevention of post-transplant cardiovascular disease--report and recommendations of an ad hoc group

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.09.026

7 January 2021

Cardiovascular risk factors and estimated risk for CAD in a randomized trial comparing calcineurin inhibitors in renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.09.026

7 January 2021

Testosterone concentrations and sirolimus in male renal transplant patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.09.026

7 January 2021

Exposure-response relationships for everolimus in de novo kidney transplantation: defining a therapeutic range

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.09.026

7 January 2021

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.09.026

7 January 2021

The Banff 97 working classification of renal allograft pathology

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.09.026

7 January 2021

Everolimus with optimized cyclosporine dosing in renal transplant recipients: 6-month safety and efficacy results of two randomized studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.09.026

7 January 2021

Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts: a phase II trial. Rapamune Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.09.026

7 January 2021

Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.09.026

7 January 2021

A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.09.026

7 January 2021

Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.09.026

7 January 2021

Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.09.026

7 January 2021

Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.09.026

7 January 2021

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.09.026

7 January 2021

Effect of renal transplantation on sperm quality and sex hormone levels

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.09.026

7 January 2021

Time course of serum prolactin and sex hormones following successful renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.09.026

7 January 2021

Impact of renal transplantation on gonadal function in male uremic patients-our experience

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.09.026

7 January 2021

Preclinical evaluation of a new potent immunosuppressive agent, rapamycin

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.09.026

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.TRANSPROCEED.2004.09.026

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15866684%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15866684%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46468654&oldid=1578272309"